Limber Prosthetics
San Diego, US · Founded 2022 · Delaware corporation
Limber Prosthetics builds 3D-printed prosthetic devices and a digital scan-design-fabricate workflow for orthotics and prosthetics (O&P) clinicians. Its flagship product, the Px1, is a monolithic, fully alignable transtibial prosthesis designed individually per patient.
HardwareHealthtechMedical Devices
Founders & leadership
LD
Luca DeVivo NicolosoExecutive Officer, Director
JS
Joshua Stephen PelzExecutive Officer, Director
HJ
Herbert Joseph BarrackExecutive Officer, Director
WW
Walker WhiteExecutive Officer
Competitors · 3
by search overlapCleveland Clinic, 202277 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Diabetes Prevention Program56 shared keywords
Open Bionics38 shared keywordsOpen Bionics develops 3D-printed bionic hands called the Hero Arm, designed to be affordable, functional, and aesthetically appealing alternatives to traditional prostheses. The company serves individuals with upper limb differences and limb loss, operating in the medical devices and assistive technology space.
Companies competing with Limber Prosthetics for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$3.8MraisedJun 2025 · 40 investors · Other Health CareRule 506(b)
▶$3.8MraisedJun 2025 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Herbert Joseph BarrackExecutive Officer, Director
- Luca DeVivo NicolosoExecutive Officer, Director
- Joshua Stephen PelzExecutive Officer, Director
- Walker WhiteExecutive Officer
- Offering amount
- $5.3M
- Amount sold
- $3.8M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $247.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.